Tissue Repair Peptide Research: BPC-157, TB-500 and GHK-Cu

Three peptides turn up again and again in preclinical papers on tissue biology: BPC-157, TB-500 and GHK-Cu. This overview describes what the published literature reports at a high level. It is educational and for laboratory research use only; none of these compounds is approved for use in people, and nothing here is medical advice.

BPC-157

BPC-157 is a synthetic pentadecapeptide, meaning a chain of fifteen amino acids, whose sequence is derived from a protein found in gastric juice. Most published work comes from rodent studies and cell cultures examining how it may influence processes such as angiogenesis, growth-factor signalling and the response of tendon, gut and other tissues to injury. Human clinical evidence is very limited, which is one reason it is sold only as a research material. See the individual BPC-157 vial or the BPC-157 capsules for the research formats we list.

TB-500

TB-500 is a synthetic fragment related to thymosin beta-4, a naturally occurring peptide involved in actin regulation, cell migration and wound-healing models. Laboratory studies of thymosin beta-4 and its fragments examine how cells move and how tissues respond in injury models. It is most often encountered in research as a partner to BPC-157.

GHK-Cu

GHK-Cu is a small copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first isolated from human plasma. In vitro and animal studies have examined its effects on collagen synthesis, extracellular-matrix remodelling and gene expression in skin and other cell types, and it has long been a subject of cosmetic-science research.

Why they are studied together

Because tissue repair is a multi-step process, researchers sometimes want to examine several mechanisms side by side. That is the logic behind the blends in our Blends category: the Wolverine blend pairs BPC-157 with TB-500, and GLOW combines GHK-Cu, BPC-157 and TB-500 in one vial.

Documentation matters most with blends

A blend has more ways to go wrong than a single peptide: each component needs its own identity and quantity check. The independent reports published on the COAs page list a separate assay for each component. For example, the GLOW report lists GHK-Cu, BPC-157 and TB-500 individually, and the Wolverine report adds heavy-metal, endotoxin and sterility panels. Learn to read them in our COA guide.

Limits of the evidence

Animal and cell results do not establish safety or effectiveness in people, and conditions in a dish differ from those in a body. Treat the literature as a map of hypotheses rather than answers. The companion news item is BPC-157, GHK-Cu, Wolverine and GLOW reports released.